Growth Metrics

Evolus (EOLS) R&D In Process (2022)

Evolus filings provide 1 years of R&D In Process readings, the most recent being $2.0 million for Q2 2022.

  • On a quarterly basis, R&D In Process changed N/A to $2.0 million in Q2 2022 year-over-year; TTM through Dec 2022 was $2.0 million, a N/A change, with the full-year FY2022 number at $2.0 million, changed N/A from a year prior.
  • R&D In Process hit $2.0 million in Q2 2022 for Evolus.
  • In the past five years, R&D In Process ranged from a high of $2.0 million in Q2 2022 to a low of $2.0 million in Q2 2022.